Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells
- Authors:
- Yan Zheng
- Hongmei Nan
- Miao Hao
- Chengcheng Song
- Yifa Zhou
- Yufei Gao
View Affiliations
Affiliations: China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China, The First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, P.R. China
- Published online on: May 10, 2013 https://doi.org/10.3892/br.2013.104
-
Pages:
555-558
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Ginsenosides are the main biologically active components of ginseng. In this study, seven types of protopanaxadiol ginsenosides were assessed for their antiproliferative activity on the HCT‑116 and HT‑29 human colorectal cancer cell lines using the 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide (MTT) assay. The experimental results indicated that the native protopanaxadiol ginsenosides Rb1 and Rb2 inhibited the proliferation of the colorectal cancer cells in a dose‑dependent manner. The deglycosylation products F2 and CO (from ginsenosides Rb1 and Rb2, respectively) significantly inhibited the growth of the human colorectal cancer cell lines, whereas product C‑K (from Rb1 and Rb2) exerted no antiproliferative effects on the cancer cell lines assessed in this study. HT‑29 cells were more sensitive to these ginsenosides compared to HCT‑116 cells. In addition, the antiproliferative activity of ginsenosides was found to be correlated with the number and type of sugar residues. The potent growth inhibitory effect of protopanaxadiol ginsenosides on cancer cells may be used in the pharmaceutical industry.
View References
1.
|
Saw CL, Yang AY, Cheng DC, et al:
Pharmacodynamics of ginsenosides: antioxidant activities,
activation of Nrf2, and potential synergistic effects of
combinations. Chem Res Toxicol. 25:1574–1580. 2012. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Hashimoto R, Yu J, Koizumi H, Ouchi Y and
Okabe T: Ginsenoside Rb1 prevents MPP(+)-induced apoptosis in PC12
cells by stimulating estrogen receptors with consequent activation
of ERK1/2, Akt and inhibition of SAPK/JNK, p38 MAPK. Evid Based
Complement Alternat Med. 2012:6937172012.PubMed/NCBI
|
3.
|
Lee JS, Song JH, Sohn NW and Shin JW:
Inhibitory effects of ginsenoside Rb1 on neuroinflammation
following systemic lipopolysaccharide treatment in mice. Phytother
Res. Oct 8–2012.(Epub ahead of print).
|
4.
|
Huang X, Liu X and Deng C: Effects of the
combination of active component extracts from Astragalus
membranaceus and Panax notoginseng on apoptosis, reactive
oxygen species and mitochondrial membrane potential of PC12 cells
with oxidative injury. J Chin Integr Med. 10:1127–1134. 2012.(In
Chinese).
|
5.
|
Lee HU, Bae EA, Han MJ, Kim NJ and Kim DH:
Hepatoprotective effect of ginsenoside Rb1 and compound K on
tert-butyl hydro-peroxide-induced liver injury. Liver Int.
25:1069–1073. 2005. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Zhou W, Feng MQ, Li JY and Zhou P: Studies
on the preparation, crystal structure and bioactivity of
ginsenoside compound K. J Asian Nat Prod Res. 8:519–527. 2006.
View Article : Google Scholar : PubMed/NCBI
|
7.
|
Choi K, Kim M, Ryu J and Choi C:
Ginsenosides compound K and Rh(2) inhibit tumor necrosis
factor-alpha-induced activation of the NF-kappaB and JNK pathways
in human astroglial cells. Neurosci Lett. 421:37–41. 2007.
View Article : Google Scholar : PubMed/NCBI
|
8.
|
Zhou W, Feng M, Li X, et al: X-ray
structure investigation of
(20S)-20-O-beta-D-glucopyranosyl-protopanaxadiol and antitumor
effect on Lewis lung carcinoma in vivo. Chem Biodivers. 6:380–388.
2009. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Kim JH, Hong YH, Lee JH, et al: A role for
the carbohydrate portion of ginsenoside Rg3 in
Na+channel inhibition. Mol Cells. 19:137–142.
2005.PubMed/NCBI
|
10.
|
Chu SF and Zhang JT: New achievements in
ginseng research and its future prospects. Chin J Integr Med.
15:403–408. 2009. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Gao J, Xu W, Fang Q, et al: Efficient
biotransformation for preparation of pharmaceutically active
ginsenoside compound K by Penicillium oxalicum sp. 68. Ann
Microbiol. 63:139–149. 2013. View Article : Google Scholar
|